The O'Reilly Update, April 10, 2026

The U.S. government is facing a crisis of credibility as Iran imposes tolls on shipping through the Strait of Hormuz, violating international maritime law and prompting condemnation from allies including Britain, Japan, and Gulf states. Bill O'Reilly condemns the media for amplifying Iranian propaganda, calling it a 'new low in journalism' and accusing American outlets of reporting enemy narratives as fact. Meanwhile, the First Lady publicly denies long-standing rumors linking her to Jeffrey Epstein, calling the allegations 'completely false' and urging the public to be cautious about online misinformation. On a different front, O’Reilly highlights the explosive growth of GLP-1 weight-loss drugs, now a $60 billion industry, which have helped reduce America’s obesity rate for the first time in 50 years—but at a cost, with severe side effects and high rates of weight regain after discontinuation. Despite warnings from countries like Belgium and the UK, celebrity endorsements from figures like Elon Musk and Oprah continue to fuel demand. O’Reilly frames the GLP-1 revolution as both a medical breakthrough and a societal warning: while the drugs offer real results, their unchecked popularity and lack of long-term safety data raise ethical and public health concerns. He warns that the media’s failure to scrutinize such trends mirrors its broader failure to challenge hostile narratives, especially from adversarial nations.